These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6756834)

  • 1. Use of a physiologic pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies.
    Sorensen JT; Colton CK; Hillman RS; Soeldner JS
    Diabetes Care; 1982; 5(3):148-57. PubMed ID: 6756834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling insulin action for development of a closed-loop artificial pancreas.
    Steil GM; Clark B; Kanderian S; Rebrin K
    Diabetes Technol Ther; 2005 Feb; 7(1):94-108. PubMed ID: 15738707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.
    Qinna NA; Badwan AA
    Drug Des Devel Ther; 2015; 9():2515-25. PubMed ID: 26005328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized metabolic profile estimations using oral glucose tolerance tests.
    Lee YB; Lee JH; Park ES; Kim GY; Leem CH
    Prog Biophys Mol Biol; 2014 Sep; 116(1):25-32. PubMed ID: 25157925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
    Cottrell DA
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas.
    Marliss EB; Murray FT; Stokes EF; Zinman B; Nakhooda AF; Denoga A; Leibel BS; Albisser AM
    Diabetes; 1977 Jul; 26(7):663-72. PubMed ID: 873073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis.
    Goriya Y; Kawamori R; Shichiri M; Abe H
    Med Prog Technol; 1979 Jun; 6(3):99-108. PubMed ID: 481366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
    Ward GM; Walters JM; Barton J; Alford FP; Boston RC
    Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release.
    Guyton JR; Foster RO; Soeldner JS; Tan MH; Kahn CB; Koncz L; Gleason RE
    Diabetes; 1978 Oct; 27(10):1027-42. PubMed ID: 700259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hyperglucagonemia on blood glucose concentrations and on insulin requirements in insulin-requiring diabetes mellitus.
    Clarke WL; Santiago JV; Kipnis DM
    Diabetes; 1978 Jun; 27(6):649-52. PubMed ID: 658610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas).
    Botz CK; Leibel BS; Zingg W; Gander RE; Albisser AM
    Diabetes; 1976 Aug; 25(8):691-700. PubMed ID: 782981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man.
    Sherwin RS; Hendler RG; Felig P
    Diabetes; 1976 Sep; 25(9):776-84. PubMed ID: 955305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of physiological factors influencing glucose-insulin kinetics in diabetic patients.
    Min BG; Woo EJ; Lee HK; Min HK
    Ann Biomed Eng; 1985; 13(2):195-213. PubMed ID: 3890627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semiclosed-loop algorithm for the control of blood glucose levels in diabetics.
    Fisher ME
    IEEE Trans Biomed Eng; 1991 Jan; 38(1):57-61. PubMed ID: 2026432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical model of glucose-insulin homeostasis in healthy rats.
    Lombarte M; Lupo M; Campetelli G; Basualdo M; Rigalli A
    Math Biosci; 2013 Oct; 245(2):269-77. PubMed ID: 23911696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the physiological glucose-insulin dynamic system on diabetics.
    Chen CL; Tsai HW; Wong SS
    J Theor Biol; 2010 Aug; 265(3):314-22. PubMed ID: 20466007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs used in metabolic disorders.
    Sutton JR
    Med Sci Sports Exerc; 1981; 13(4):266-71. PubMed ID: 7024705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
    Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S
    Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.